Medicines regulator Swissmedic has approved the booster of the single-dose vaccine from Johnson & Johnson.
“The second dose of the vaccine can be administered, at the earliest, two months after the first dose,” wrote Swissmedic in a statement on Monday.
Swissmedic has also approved the use of Janssen as a booster for mRNA vaccines. It can be administered six months after the second dose of an mRNA vaccine.
“This is the first time in Switzerland that an applicant has submitted clinical data on a mixed vaccination,” wrote Swissmedic.
The Janssen viral vector model vaccine was first approved in March. In September the Swiss government signed a contract to purchase 150,000 doses. The vaccine is based on a human cold virus that contains the blueprint for the “spike” protein of the novel coronavirus.
The other two vaccines approved in Switzerland – Moderna and by Pfizer/BioNTech – use mRNA technology, a process that injects a fragment of the coronavirus blueprint into human cells to prompt the body to produce a defensive response.
Moderna boost
The Swiss government has exercised its option to purchase an additional seven million doses of Moderna’s booster vaccine for delivery in the second half of 2022, the company said on Monday. These vaccine, approved as booster in November, would be in addition to the first seven million doses ordered by the government for 2022. In total, this brings Switzerland’s order to 27.5 million doses of the mRNA vaccine.
Most Read Swiss Abroad
More
November 24, 2024 votes: the results from across Switzerland
Should raw milk sales be banned or should consumers decide?
Swiss food regulations do not allow raw milk to be sold for direct consumption. However, a loophole allows 400 raw milk vending machines to do just that.
Argentina’s Milei to visit Switzerland in January 2025
This content was published on
Argentina's libertarian President Javier Milei plans to visit Switzerland on January 24, 2025 to attend an event organised by the Liberal Institute in Zurich.
This content was published on
OpenAI, the maker of ChatGPT, says it intends to open an office in Zurich. The move is part of its European expansion plan, after setting up offices in London, Paris, Brussels and Dublin.
This content was published on
The Swiss economy is growing slightly faster than expected, according to the Organization for Economic Cooperation and Development (OECD).
This content was published on
The House of Representatives on Wednesday cut the foreign aid budget by CHF250 million ($282 million) in favour of the army.
Parliament confirms 13th pension payment to be paid once a year in December
This content was published on
The 13th old-age pension payment will be paid out as planned from December 2026, the Swiss Senate confirmed on Wednesday.
This content was published on
Around 1,000 Swiss farmers took part in a protest action near Bern on Tuesday, calling for less administrative work, more planning security and fairer prices.
UN appeals for more funds to assist 305 million people in need
This content was published on
The United Nations Office for the Coordination of Humanitarian Affairs (OCHA) estimates that around 305 million people will need aid in 2025.
Swiss authorities release right-to-die activist in Sarco ‘suicide capsule’ case
This content was published on
A right-to-die activist has been released from police custody over the reported first use of the Sarco “suicide capsule”, after prosecutors ruled out the possibility of an intentional homicide.
Switzerland demands immediate halt to hostilities in Syria
This content was published on
The Swiss foreign ministry has called for an immediate end to hostilities in Syria. International humanitarian law must be respected, it declared via the social media platform X on Tuesday.
Poll: right-wing Swiss People’s Party enjoys growing support among population
This content was published on
If national elections had been held in Switzerland last month, the right-wing Swiss People's Party would have won, and increased its share of votes by 2% compared to the 2023 federal elections.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss regulator approves Pfizer/BioNTech booster for 16 and up
This content was published on
Swissmedic has approved the extension of Covid-19 boosters to all people 16 years of age and over for the Pfizer/BioNTech vaccine.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.